Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.5.0.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2016
Mar. 31, 2016
CURRENT ASSETS    
Cash $ 556,352 $ 2,123,737
Accounts receivable 193,719 199,471
Prepaid expenses and other current assets 66,469 53,294
TOTAL CURRENT ASSETS 816,540 2,376,502
NON-CURRENT ASSETS    
Property and equipment, net 22,969 36,038
Patents and patents pending, net 89,579 94,161
Deposits 21,747 22,415
TOTAL ASSETS 950,835 2,529,116
CURRENT LIABILITIES    
Accounts payable 384,728 244,804
Due to related parties 58,362 145,112
Convertible notes payable, net - current portion 605,815 0
Other current liabilities 35,316 136,695
TOTAL CURRENT LIABILITIES 1,084,221 526,611
NONCURRENT LIABILITIES    
Convertible notes payable, net - less current portion 0 500,139
TOTAL LIABILITIES 1,084,221 1,026,750
COMMITMENTS AND CONTINGENCIES (Note 13)
EQUITY    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of September 30, 2016 and March 31, 2016; 7,711,811 and 7,622,393 shares issued and outstanding as of September 30, 2016 and March 31, 2016, respectively 7,711 7,621
Additional paid-in capital 90,811,302 88,047,142
Accumulated deficit (90,886,645) (86,502,043)
Total Aethlon Medical Inc. stockholders' (deficit) equity before noncontrolling interests (67,632) 1,552,720
Noncontrolling interest (65,754) (50,354)
Total (deficit) equity (133,386) 1,502,366
Total liabilities and equity $ 950,835 $ 2,529,116